2 completed, 1 terminated, 1 unknown. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Nausea and Vomiting: new trials by email Literature Review of Nausea and Vomiting trials Research Report on Nausea and Vomiting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation Glycopyrrolate, Anisodamine - Nausea and Vomiting | Phase 1 / Phase 2 | Completed | Jie Chen | 130 | 2023-10-01 | 2024-09-05 |
| A Clinical Study to Evaluate Cyclopofol Injection for the Prevention of Postoperative Nausea and Vomiting Heptaflurane combined Cyclophenol, Heptaflurane, Cyclophenol - Nausea and Vomiting | Phase 1 | Unknown | Mengchang Yang | 300 | 2023-08-02 | 2023-07-27 |
| Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain methadone hydrochloride, questionnaire administration, management of therapy complications - Nausea and Vomiting, Pain | Phase 1 | Terminated | NCIC Clinical Trials Group | 8 | 2010-06-17 | 2024-02-12 |
| Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer aprepitant, cyclophosphamide, placebo - Breast Cancer, Nausea and Vomiting | Phase 1 | Completed | UNC Lineberger Comprehensive Cancer Center | 19 | 2005-08-01 | 2024-11-04 |
Nausea (4) · Vomiting (4) · Breast Neoplasms (1) · Pain (1) · Sleep Wake Disorders (1)
Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Signs and Symptoms, Digestive (4) · Breast Diseases (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Aprepitant (1) · Cyclophosphamide (1) · Glycopyrrolate (1) · Methadone (1) · anisodamine (1)
Jie Chen (1) · Mengchang Yang (1) · NCIC Clinical Trials Group (1) · UNC Lineberger Comprehensive Cancer Center (1)
China (2) · Canada (1) · United States (1)
Bruno Gagnon, MD, MSC (1) · Christine M. Walko, PharmD, BCOP (1) · Guangyou Duan, doctor (1) · Ray Viola (1)
P30CA016086 (1)